201 related articles for article (PubMed ID: 22908168)
1. Human cytomegalovirus inhibitor AL18 also possesses activity against influenza A and B viruses.
Muratore G; Mercorelli B; Goracci L; Cruciani G; Digard P; Palù G; Loregian A
Antimicrob Agents Chemother; 2012 Nov; 56(11):6009-13. PubMed ID: 22908168
[TBL] [Abstract][Full Text] [Related]
2. Protein-protein interactions by influenza polymerase subunits as drug targets.
Felicetti T; Massari S
Future Med Chem; 2022 Jan; 14(2):53-56. PubMed ID: 34730024
[No Abstract] [Full Text] [Related]
3. Zanamivir. A potent and selective inhibitor of influenza A and B viruses.
Aoki FY; Hayden FG
Clin Pharmacokinet; 1999; 36 Suppl 1():v-ix. PubMed ID: 10429834
[No Abstract] [Full Text] [Related]
4. Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase.
Muratore G; Goracci L; Mercorelli B; Foeglein Á; Digard P; Cruciani G; Palù G; Loregian A
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6247-52. PubMed ID: 22474359
[TBL] [Abstract][Full Text] [Related]
5. The active form of the influenza cap-snatching endonuclease inhibitor baloxavir marboxil is a tight binding inhibitor.
Todd B; Tchesnokov EP; Götte M
J Biol Chem; 2021; 296():100486. PubMed ID: 33647314
[TBL] [Abstract][Full Text] [Related]
6. Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay.
Eichelberger MC; Hassantoufighi A; Wu M; Li M
Virol J; 2008 Sep; 5():109. PubMed ID: 18822145
[TBL] [Abstract][Full Text] [Related]
7. Exploration of the 2,3-dihydroisoindole pharmacophore for inhibition of the influenza virus PA endonuclease.
Rogolino D; Naesens L; Bartoli J; Carcelli M; De Luca L; Pelosi G; Stokes RW; Van Berwaer R; Vittorio S; Stevaert A; Cohen SM
Bioorg Chem; 2021 Nov; 116():105388. PubMed ID: 34670331
[TBL] [Abstract][Full Text] [Related]
8. Focusing on the Influenza Virus Polymerase Complex: Recent Progress in Drug Discovery and Assay Development.
Zhang J; Hu Y; Musharrafieh R; Yin H; Wang J
Curr Med Chem; 2019; 26(13):2243-2263. PubMed ID: 29984646
[TBL] [Abstract][Full Text] [Related]
9. 1,2,3-Triazolyl-4-oxoquinolines: A feasible beginning for promising chemical structures to inhibit oseltamivir-resistant influenza A and B viruses.
Boechat Fda C; Sacramento CQ; Cunha AC; Sagrillo FS; Nogueira CM; Fintelman-Rodrigues N; Santos-Filho O; Riscado CS; Forezi Lda S; Faro LV; Brozeguini L; Marques IP; Ferreira VF; Souza TM; de Souza MC
Bioorg Med Chem; 2015 Dec; 23(24):7777-84. PubMed ID: 26643220
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of sialidase activity as a therapeutic approach.
Glanz VY; Myasoedova VA; Grechko AV; Orekhov AN
Drug Des Devel Ther; 2018; 12():3431-3437. PubMed ID: 30349196
[TBL] [Abstract][Full Text] [Related]
11. Baloxavir marboxil (Xofluza) for treatment of influenza.
Med Lett Drugs Ther; 2018 Dec; 60(1561):193-196. PubMed ID: 30653474
[No Abstract] [Full Text] [Related]
12. Lead Optimization of Influenza Virus RNA Polymerase Inhibitors Targeting PA-PB1 Interaction.
Mizuta S; Otaki H; Ishikawa T; Makau JN; Yamaguchi T; Fujimoto T; Takakura N; Sakauchi N; Kitamura S; Nono H; Nishi R; Tanaka Y; Takeda K; Nishida N; Watanabe K
J Med Chem; 2022 Jan; 65(1):369-385. PubMed ID: 34905383
[TBL] [Abstract][Full Text] [Related]
13. Dihydromyricetin is a new inhibitor of influenza polymerase PB2 subunit and influenza-induced inflammation.
Tian Y; Sang H; Liu M; Chen F; Huang Y; Li L; Liu S; Yang J
Microbes Infect; 2020; 22(6-7):254-262. PubMed ID: 32554102
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitors.
Zima V; Radilová K; Kožíšek M; Albiñana CB; Karlukova E; Brynda J; Fanfrlík J; Flieger M; Hodek J; Weber J; Majer P; Konvalinka J; Machara A
Eur J Med Chem; 2020 Dec; 208():112754. PubMed ID: 32883638
[TBL] [Abstract][Full Text] [Related]
15. Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.
Wunderlich K; Mayer D; Ranadheera C; Holler AS; Mänz B; Martin A; Chase G; Tegge W; Frank R; Kessler U; Schwemmle M
PLoS One; 2009 Oct; 4(10):e7517. PubMed ID: 19841738
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase.
Massari S; Bertagnin C; Pismataro MC; Donnadio A; Nannetti G; Felicetti T; Di Bona S; Nizi MG; Tensi L; Manfroni G; Loza MI; Sabatini S; Cecchetti V; Brea J; Goracci L; Loregian A; Tabarrini O
Eur J Med Chem; 2021 Jan; 209():112944. PubMed ID: 33328103
[TBL] [Abstract][Full Text] [Related]
17. Eukaryotic Translation Elongation Factor 1 Delta Inhibits the Nuclear Import of the Nucleoprotein and PA-PB1 Heterodimer of Influenza A Virus.
Gao Q; Yang C; Ren C; Zhang S; Gao X; Jin M; Chen H; Ma W; Zhou H
J Virol; 2020 Dec; 95(2):. PubMed ID: 33087462
[TBL] [Abstract][Full Text] [Related]
18. Neuraminidase from Influenza A and B Viruses is Susceptible to the Compound 4-(4-Phenyl-1H-1,2,3-Triazol-1-yl)-2,2,6,6-Tetramethylpiperidine-1- Oxyl.
Sacramento CQ; Jordão AK; Abrantes JL; Alves CM; Marttorelli A; Fintelman-Rodrigues N; de Freitas CS; de Melo GR; Cunha AC; Ferreira VF; Souza TML
Curr Top Med Chem; 2020; 20(2):132-139. PubMed ID: 31880262
[TBL] [Abstract][Full Text] [Related]
19. In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit.
Noshi T; Kitano M; Taniguchi K; Yamamoto A; Omoto S; Baba K; Hashimoto T; Ishida K; Kushima Y; Hattori K; Kawai M; Yoshida R; Kobayashi M; Yoshinaga T; Sato A; Okamatsu M; Sakoda Y; Kida H; Shishido T; Naito A
Antiviral Res; 2018 Dec; 160():109-117. PubMed ID: 30316915
[TBL] [Abstract][Full Text] [Related]
20. Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada.
Abed Y; Fage C; Lagüe P; Carbonneau J; Papenburg J; Vinh DC; Boivin G
Emerg Infect Dis; 2019 Apr; 25(4):838-840. PubMed ID: 30882323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
